Drug Type Small molecule drug |
Synonyms Aescine Sodium Liniment, 欧开, 麦通纳 |
Target |
Action agonists |
Mechanism PGF2α agonists(Prostaglandin F2 alpha agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (26 May 1995), |
Regulation- |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Brain Edema | China | 26 May 1995 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Edema | Phase 2 | China | 26 Nov 2009 | |
| Tumescence | Phase 2 | China | 13 Aug 2009 | |
| anal or rectal varicose veins | Phase 1 | China | 15 Dec 2017 | |
| Brain Concussion | Phase 1 | China | 15 Dec 2017 | |
| Leg/buttock pain | Phase 1 | China | 15 Dec 2017 | |
| Soft tissue swelling | Phase 1 | China | 15 Dec 2017 | |
| Spinal Cord Injuries | Phase 1 | China | 15 Dec 2017 |





